Avid Bioservices Inc (CDMO)

[swg_tdr]

EXOSOME pricing point/breast cancer

looks like 2013, from comments on NYT article

LizNewton, MA
What I want to know is why the testing in Israel is stated to be $100 - presume this means the BRCA testing and in the US, this test is held patented by Myriad genetics - the majority of it not covered by insurance and ran me nearly $3k out of pocket. Hopefully this ruling against Myriad will mean more at risk women can get this important test and not have to pay the ridiculous fees that I had.

http://www.nytimes.com/2013/06/14/us/supreme-court-rules-human-genes-may...
Nov. 27, 2013 at 7:26 p.m.RECOMM

tests for breast cancer in Israel are now twice a year, free for "at risk groups"

we have a goldmine, folks -- forget about 61 cents, the pending Reverse, or Bavi. but those folks called management have to get their act together.